Grace Therapeutics (NASDAQ:GRCE) Releases Earnings Results, Beats Expectations By $0.04 EPS

Grace Therapeutics (NASDAQ:GRCE) issued its earnings results on Thursday. The company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.04, FiscalAI reports.

Grace Therapeutics Price Performance

GRCE traded down $0.02 during trading on Thursday, hitting $1.83. 72,594 shares of the stock traded hands, compared to its average volume of 345,710. The firm has a market capitalization of $38.60 million, a P/E ratio of -1.56 and a beta of 0.43. Grace Therapeutics has a 12-month low of $1.67 and a 12-month high of $5.18. The firm has a 50-day moving average of $2.02 and a 200 day moving average of $2.76.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Wall Street Zen lowered Grace Therapeutics from a “sell” rating to a “strong sell” rating in a research report on Saturday, November 7th. Zacks Research upgraded Grace Therapeutics to a “hold” rating in a research report on Monday, August 3rd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Grace Therapeutics in a research report on Thursday, October 15th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $6.00.

Grace Therapeutics Company Profile

Grace Therapeutics, Inc. (NASDAQ: GRCE) is a clinical-stage biopharmaceutical company developing therapies for rare and life-threatening medical conditions. The company focuses on drug-delivery technologies intended to improve the administration, absorption, and therapeutic performance of established pharmaceutical compounds. Grace Therapeutics’ lead candidate is GTx-104, an investigational injectable formulation of nimodipine being developed for patients with aneurysmal subarachnoid hemorrhage, a serious form of bleeding around the brain.